Andrea Apolo, Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic at the National Cancer Institute, shared a post on X:
“Very proud of our own Saad Atiq National Cancer Institute senior fellow presenting data on the Prevalence of Histology-Agnostic Biomarkers in Pure Squamous Cell Carcinomas of the Bladder showing 1/3 of patients with TMB-High.”
Andrea Apolo highlighted new findings presented by Saad Atiq on histology-agnostic biomarkers in pure squamous cell carcinomas of the bladder. The data revealed that one-third of these patients exhibited TMB-High, indicating potential implications for targeted therapies.
More posts featuring Andrea Apolo.